Filing Details

Accession Number:
0000310764-24-000102
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-08 16:23:01
Reporting Period:
2024-08-06
Accepted Time:
2024-08-08 16:23:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310764 Stryker Corp SYK Surgical & Medical Instruments & Apparatus (3841) 381239739
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242914 E Ronda Stryker 1941 Stryker Way
Portage MI 49002
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-08-06 14,925 $0.00 3,506,608 No 4 G Indirect By Revocable Trust
Common Stock Disposition 2024-08-06 2,121 $316.95 3,504,487 No 4 S Indirect By Revocable Trust
Common Stock Disposition 2024-08-06 3,079 $317.69 3,501,408 No 4 S Indirect By Revocable Trust
Common Stock Disposition 2024-08-06 3,594 $319.56 3,497,814 No 4 S Indirect By Revocable Trust
Common Stock Disposition 2024-08-06 6,084 $320.47 3,491,730 No 4 S Indirect By Revocable Trust
Common Stock Disposition 2024-08-06 3,944 $321.43 3,487,786 No 4 S Indirect By Revocable Trust
Common Stock Disposition 2024-08-06 48,098 $322.64 3,439,688 No 4 S Indirect By Revocable Trust
Common Stock Disposition 2024-08-06 41,519 $323.52 3,398,169 No 4 S Indirect By Revocable Trust
Common Stock Disposition 2024-08-06 58,631 $324.48 3,339,538 No 4 S Indirect By Revocable Trust
Common Stock Disposition 2024-08-06 17,927 $325.45 3,321,611 No 4 S Indirect By Revocable Trust
Common Stock Disposition 2024-08-06 5,003 $326.06 3,316,608 No 4 S Indirect By Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Indirect By Revocable Trust
No 4 S Indirect By Revocable Trust
No 4 S Indirect By Revocable Trust
No 4 S Indirect By Revocable Trust
No 4 S Indirect By Revocable Trust
No 4 S Indirect By Revocable Trust
No 4 S Indirect By Revocable Trust
No 4 S Indirect By Revocable Trust
No 4 S Indirect By Revocable Trust
No 4 S Indirect By Revocable Trust
No 4 S Indirect By Revocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,050,915 Indirect By L. Lee Stryker Trust
Common Stock 3,940 Direct
Common Stock 37,600 Indirect By 1988 William D. Johnston Trust
Footnotes
  1. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $316.01 to $316.95, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  2. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $317.01 to $317.81, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  3. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $318.99 to $319.86, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  4. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $320.15 to $320.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  5. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $321.05 to $321.66, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  6. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $322.05 to $322.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  7. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $323.01 to $323.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  8. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $324.00 to $324.93, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  9. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $325.00 to $325.98, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  10. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $326.00 to $326.13, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.